綜醫研控股
2385
GIG Works
2375
note
5243
Renascience
4889
ReYuu Japan
9425
(FY)2024/06/30 | (Q4)2024/06/30 | (Q3)2024/03/31 | (Q2)2023/12/31 | (Q1)2023/09/30 | (FY)2023/06/30 | (Q4)2023/06/30 | (Q3)2023/03/31 | (Q2)2022/12/31 | (Q1)2022/09/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 22.02%168.59億 | 32.44%49.77億 | 29.80%47.21億 | 16.68%40.11億 | 5.59%31.51億 | 19.11%138.16億 | 14.83%37.58億 | 24.71%36.37億 | 13.62%34.38億 | 25.09%29.84億 |
主營業務成本 | 17.15%64.63億 | 26.04%19.81億 | 18.65%16.21億 | 15.59%16.16億 | 5.43%12.45億 | 22.51%55.17億 | 19.00%15.71億 | 30.28%13.66億 | 13.52%13.98億 | 30.89%11.81億 |
毛利 | 25.26%103.96億 | 37.04%29.96億 | 36.51%30.99億 | 17.42%23.95億 | 5.70%19.06億 | 16.95%82.99億 | 12.01%21.86億 | 21.58%22.71億 | 13.68%20.4億 | 21.56%18.03億 |
營業費用 | 29.70%80.23億 | 31.24%22.12億 | 41.04%22.44億 | 27.09%19.07億 | 17.81%16.59億 | 18.12%61.86億 | 12.00%16.86億 | 23.44%15.91億 | 20.50%15億 | 17.62%14.09億 |
營業利潤 | 12.29%23.74億 | 56.56%7.83億 | 25.91%8.56億 | -9.50%4.88億 | -37.55%2.46億 | 13.65%21.14億 | 12.06%5億 | 17.44%6.8億 | -1.77%5.39億 | 38.09%3.95億 |
營業外利息收入與支出淨額 | -69.13%222.7萬 | -111.64%-43.5萬 | -223.63%-242.2萬 | 24.61%248.6萬 | 642.38%259.8萬 | 63.49%721.3萬 | 289.38%373.8萬 | 7.11%195.9萬 | 101.92%199.5萬 | -175.43%-47.9萬 |
營業外利息收入 | 77.97%1,891.5萬 | 14.43%577.2萬 | 94.59%468萬 | 423.94%420.2萬 | 79.26%426.1萬 | 46.15%1,062.8萬 | 280.11%504.4萬 | -12.77%240.5萬 | -58.66%80.2萬 | 90.46%237.7萬 |
營業外利息支出 | 388.67%1,668.8萬 | 375.27%620.7萬 | 1,492.38%710.2萬 | 243.84%171.6萬 | -41.77%166.3萬 | 19.41%341.5萬 | 255.86%130.6萬 | -51.94%44.6萬 | -225.32%-119.3萬 | 365.91%285.6萬 |
投資淨收益 | 304.40%8,241.7萬 | 71.46%4,676.3萬 | 6,371.91%4,400.9萬 | 26.85%-1,789.5萬 | -43.52%954萬 | -65.60%2,038萬 | -7.23%2,727.4萬 | -96.37%68萬 | -426.84%-2,446.4萬 | 363.88%1,689萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | ||||||||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | 86.94%-1,881.7萬 | 86.24%-1,881.7萬 | 0 | -2,107.81%-1.44億 | -1,994.44%-1.37億 | 136.9萬 | ||||
減:重組及並購 | ---1,832.7萬 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
減:其他特殊費用 | ---- | ---- | ---- | ---- | ---- | 5.18%686.5萬 | ---53.5萬 | ---136.9萬 | ---- | ---- |
減:勾銷 | -72.93%3,714.4萬 | ---- | ---- | ---- | ---- | --1.37億 | ---- | ---- | ---- | ---- |
其他營業外收入(費用) | 23.92%5,202.1萬 | 17.11%1,706萬 | 19.16%1,393.9萬 | -23.59%786.5萬 | 142.70%1,315.7萬 | 4.70%4,198萬 | 76.35%1,456.8萬 | 4.91%1,169.8萬 | 2.85%1,029.3萬 | -49.22%542.1萬 |
稅前利潤 | 22.17%24.91億 | 102.30%8.28億 | 31.05%9.11億 | -7.30%4.8億 | -34.75%2.72億 | 4.20%20.39億 | -14.49%4.09億 | 13.92%6.95億 | -8.66%5.18億 | 38.48%4.16億 |
所得稅 | 57.12%8.37億 | 299.12%2.69億 | 40.79%2.2億 | 38.33%2.31億 | -17.57%1.17億 | -7.33%5.33億 | -51.47%6,741.1萬 | 5.19%1.56億 | -5.29%1.67億 | 27.82%1.42億 |
除稅後利潤 | 9.81%16.54億 | 63.50%5.59億 | 28.23%6.91億 | -28.97%2.5億 | -43.67%1.54億 | 8.99%15.06億 | 0.63%3.42億 | 16.72%5.39億 | -10.18%3.51億 | 44.75%2.74億 |
持續經營利潤 | 9.81%16.54億 | 63.50%5.59億 | 28.23%6.91億 | -28.97%2.5億 | -43.67%1.54億 | 8.99%15.06億 | 0.63%3.42億 | 16.72%5.39億 | -10.18%3.51億 | 44.75%2.74億 |
歸屬于少數股東的淨利潤 | 46.02%1,742.8萬 | 166.93%319.8萬 | 28.05%1,345.5萬 | -40.53%35.8萬 | -92.56%41.7萬 | 1,193.5萬 | -722.38%-477.8萬 | 1,708.61%1,050.8萬 | 60.2萬 | 560.3萬 |
歸屬於母公司的淨利潤 | 9.52%16.37億 | 60.32%5.56億 | 28.23%6.78億 | -28.95%2.49億 | -42.65%1.54億 | 8.13%14.94億 | 1.86%3.47億 | 14.59%5.28億 | -10.34%3.51億 | 41.79%2.69億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 9.52%16.37億 | 60.32%5.56億 | 28.23%6.78億 | -28.95%2.49億 | -42.65%1.54億 | 8.13%14.94億 | 1.86%3.47億 | 14.59%5.28億 | -10.34%3.51億 | 41.79%2.69億 |
總派息金額 | ||||||||||
基本每股收益 | 10.50%348.42 | 60.90%118.65 | 29.41%144.05 | -28.19%52.98 | -42.03%32.74 | 9.29%315.31 | 3.00%73.74 | 15.86%111.31 | -9.38%73.78 | 43.28%56.48 |
稀釋每股收益 | 10.50%348.42 | 61.00%118.65 | 29.41%144.05 | -28.19%52.9775 | -42.03%32.74 | 9.29%315.31 | 2.95%73.6948 | 15.86%111.31 | -9.39%73.7737 | 43.28%56.48 |
每股派息 | 4.17%25 | 4.17%25 | 0 | 0 | 0 | 9.09%24 | 9.09%24 | 0 | 0 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |